- Home
- SLNO vs CAAP Comparison
SLNO vs CAAP Comparison
Compare SLNO & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- CAAP
- Stock Information
- Founded
- SLNO 1999
- CAAP 1998
- Country
- SLNO United States
- CAAP Luxembourg
- Employees
- SLNO N/A
- CAAP N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CAAP Aerospace
- Sector
- SLNO Health Care
- CAAP Consumer Discretionary
- Exchange
- SLNO Nasdaq
- CAAP Nasdaq
- Market Cap
- SLNO 3.8B
- CAAP 3.3B
- IPO Year
- SLNO 2014
- CAAP 2018
- Fundamental
- Price
- SLNO $87.64
- CAAP $20.05
- Analyst Decision
- SLNO Strong Buy
- CAAP Strong Buy
- Analyst Count
- SLNO 9
- CAAP 2
- Target Price
- SLNO $105.11
- CAAP $24.35
- AVG Volume (30 Days)
- SLNO 1.6M
- CAAP 124.5K
- Earning Date
- SLNO 08-06-2025
- CAAP 08-20-2025
- Dividend Yield
- SLNO N/A
- CAAP N/A
- EPS Growth
- SLNO N/A
- CAAP N/A
- EPS
- SLNO N/A
- CAAP 1.05
- Revenue
- SLNO N/A
- CAAP $1,858,038,000.00
- Revenue This Year
- SLNO N/A
- CAAP $0.91
- Revenue Next Year
- SLNO N/A
- CAAP $12.63
- P/E Ratio
- SLNO N/A
- CAAP $18.61
- Revenue Growth
- SLNO N/A
- CAAP 28.46
- 52 Week Low
- SLNO $41.50
- CAAP $13.97
- 52 Week High
- SLNO $90.32
- CAAP $22.13
- Technical
- Relative Strength Index (RSI)
- SLNO 61.36
- CAAP 50.21
- Support Level
- SLNO $79.70
- CAAP $19.30
- Resistance Level
- SLNO $90.32
- CAAP $20.70
- Average True Range (ATR)
- SLNO 3.43
- CAAP 0.59
- MACD
- SLNO -0.14
- CAAP -0.04
- Stochastic Oscillator
- SLNO 74.76
- CAAP 45.45
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.